Literature DB >> 7042525

Molecular pathology in inherited disorders of collagen metabolism.

P H Byers, G S Barsh, K A Holbrook.   

Abstract

During the last ten years remarkable progress has been made in understanding basic aspects of collagen metabolism, and recently this new information has been applied to an analysis of disease processes in human beings and animals. As a result, abnormalities in the structure of the constituent chains of types I and III collagens and in post-translational modifications of these molecules have been identified (fig. 2). Furthermore, the pathophysiologic effects on tissues are becoming better understood, and diagnostic tests, including prenatal diagnosis, for specific disorders are becoming available. These diseases have provided many opportunities for research into the mechanisms by which collagen biosynthesis is regulated, the requirements for secretion, the role of specific collagens in tissues, and the function of certain crosslinks. As genomic probes for the different collagen genes are developed, the contributions of studies of these diseases to an understanding of gene structure and function can only increase, as will the opportunities for more detailed approaches to molecular analysis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042525     DOI: 10.1016/s0046-8177(82)80112-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Fatal splenic rupture in Ehlers-Danlos syndrome.

Authors:  S C Harris; D N Slater; C A Austin
Journal:  Postgrad Med J       Date:  1985-03       Impact factor: 2.401

2.  An unusual pattern of peptide-bound lysine metabolism in collagen from an infant with lethal perinatal osteogenesis imperfecta.

Authors:  O M Petrovic; E J Miller
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

3.  Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.

Authors:  J F Bateman; T Mascara; D Chan; W G Cole
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.